These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 11496621)

  • 1. [Genetically engineered drugs and their application with the example of erythropoietin].
    Donatz V; Zahner J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Jul; 36(7):440-4. PubMed ID: 11496621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent progress in biomolecular engineering.
    Ryu DD; Nam DH
    Biotechnol Prog; 2000; 16(1):2-16. PubMed ID: 10662483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mammalian artificial chromosome engineering system (ACE System) applicable to biopharmaceutical protein production, transgenesis and gene-based cell therapy.
    Lindenbaum M; Perkins E; Csonka E; Fleming E; Garcia L; Greene A; Gung L; Hadlaczky G; Lee E; Leung J; MacDonald N; Maxwell A; Mills K; Monteith D; Perez CF; Shellard J; Stewart S; Stodola T; Vandenborre D; Vanderbyl S; Ledebur HC
    Nucleic Acids Res; 2004 Dec; 32(21):e172. PubMed ID: 15585659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biotech pharmaceuticals and biotherapy: an overview.
    Steinberg FM; Raso J
    J Pharm Pharm Sci; 1998; 1(2):48-59. PubMed ID: 10945918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purified protein products of rDNA technology expressed in animal cell culture.
    Lubiniecki AS; Lupker JH
    Biologicals; 1994 Jun; 22(2):161-9. PubMed ID: 7522477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biopharmaceuticals derived from genetically modified plants.
    Goldstein DA; Thomas JA
    QJM; 2004 Nov; 97(11):705-16. PubMed ID: 15496527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant DNA manipulations and their interfaces with protein technology.
    Nagley P
    Dev Biol Stand; 1987; 67():171-6. PubMed ID: 3475224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of erythropoietin gene expression and its use in medicine.
    Jelkmann W
    Methods Enzymol; 2007; 435():179-97. PubMed ID: 17998055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering cell physiology to enhance recombinant protein production in Escherichia coli.
    Chou CP
    Appl Microbiol Biotechnol; 2007 Sep; 76(3):521-32. PubMed ID: 17571257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biopharmaceuticals in China.
    Hu X; Ma Q; Zhang S
    Biotechnol J; 2006 Nov; 1(11):1215-24. PubMed ID: 17089435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Road to precision: recombinase-based targeting technologies for genome engineering.
    Wirth D; Gama-Norton L; Riemer P; Sandhu U; Schucht R; Hauser H
    Curr Opin Biotechnol; 2007 Oct; 18(5):411-9. PubMed ID: 17904350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic applications of genetic engineering].
    Descamps JL
    Ann Pharm Fr; 1994; 52(6):294-302. PubMed ID: 7864529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of recombinant DNA technology for engineering mammalian cells to produce proteins.
    Kaufman RJ
    Bioprocess Technol; 1990; 10():15-69. PubMed ID: 1367057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advances in gene engineering of microorganisms].
    Debabov VG
    Genetika; 1987 Oct; 23(10):1741-8. PubMed ID: 3121437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical engineering.
    Carrondo MJ; Aunins JG
    Curr Opin Biotechnol; 2004 Oct; 15(5):441-3. PubMed ID: 15464375
    [No Abstract]   [Full Text] [Related]  

  • 16. Plant protoplasts: status and biotechnological perspectives.
    Davey MR; Anthony P; Power JB; Lowe KC
    Biotechnol Adv; 2005 Mar; 23(2):131-71. PubMed ID: 15694124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Progress on engineered strains for ethanol production].
    Wang FQ; Xu P
    Wei Sheng Wu Xue Bao; 2006 Aug; 46(4):673-5. PubMed ID: 17037078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Special conditions for the cultivation of genetically engineered microorganisms].
    Krug M; Weide H
    Zentralbl Mikrobiol; 1987; 142(8):595-604. PubMed ID: 3328447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of new cell lines for animal cell biotechnology.
    MacDonald C
    Crit Rev Biotechnol; 1990; 10(2):155-78. PubMed ID: 2202521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fish vaccine antigens produced or delivered by recombinant DNA technologies.
    Leong JC; Anderson E; Bootland LM; Chiou PW; Johnson M; Kim C; Mourich D; Trobridge G
    Dev Biol Stand; 1997; 90():267-77. PubMed ID: 9270855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.